MedTrace Logo

The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis

NCT01676155 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2012-08-30

No results posted yet for this study

Summary

To compare the serum apoptosis-associated markers between patients with active TB and patients with LTBI To evaluate the efficiency of apoptosis-associated markers to differentiate potential of active TB from LTBI

Conditions

  • To Compare the Serum Apoptosis-associated Markers Between Patients With Active TB and Patients With LTBI
  • To Evaluate the Efficiency of Apoptosis-associated Markers to Differentiate Potential of Active TB From LTBI

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chin-Chung Shu, MD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01676155 on ClinicalTrials.gov